tisleizumab
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for tisleizumab, covering 2022-03-22 to 2024-02-16. Get the full timeline:
Most recent: Clinical Trial Update: Neoadjuvant Tisleizumab(BGB-A317) for dMMR/MSI-H Non-late Stage CRC Patients Before Surgery [Phase 2]